A CALIFORNIA JURY has ordered Johnson & Johnson to pay $417 million (about €354 million) to a woman who claimed she developed terminal ovarian cancer after using the company’s talc-based products.
The case is one of thousands of lawsuits being brought throughout the US alleging that the company failed to warn consumers of the risk of cancer from talc in its products.
The jury made the award, which included $347 million (about €295 million) in punitive damages, to Eva Echeverria after she filed suit in July of last year, a representative of the Los Angeles Superior Court told AFP.
Echeverria, 63, developed the disease after decades of using Johnson & Johnson talc-based powders for feminine hygiene, according to media reports.
In a statement, Johnson & Johnson said it would lodge an appeal.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder,” company spokesperson Carol Goodrich said in a statement.
She cited the editorial board of the US National Cancer Institute’s Physician Data Query, which wrote in April that the “weight of evidence does not support” the existence of a link between ovarian cancer and exposure of the genital region to talc.
So far, juries in St Louis, Missouri have also awarded damages against Johnson & Johnson totalling more than $307 million (about €260 million) in similar talc cases.